<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">74272</article-id><article-id pub-id-type="doi">10.7554/eLife.74272</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Robust T cell activation requires an eIF3-driven burst in T cell receptor translation</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-255579"><name><surname>DeSilva</surname><given-names>Dasmanthie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-10"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-255580"><name><surname>Ferguson</surname><given-names>Lucas</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-255581"><name><surname>Chin</surname><given-names>Grant H</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-255582"><name><surname>Smith</surname><given-names>Benjamin E</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-255583"><name><surname>Apathy</surname><given-names>Ryan A</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-255584"><name><surname>Roth</surname><given-names>Theodore L</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-255585"><name><surname>Blaeschke</surname><given-names>Franziska</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-11"/><xref ref-type="other" rid="par-12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-255586"><name><surname>Kudla</surname><given-names>Marek</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-255587"><name><surname>Marson</surname><given-names>Alexander</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-13"/><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-17742"><name><surname>Ingolia</surname><given-names>Nicholas T</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3395-1545</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-7"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-4624"><name><surname>Cate</surname><given-names>Jamie HD</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5965-7902</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf5"/></contrib><aff id="aff1"><institution content-type="dept">Department of Molecular and Cell Biology</institution>, <institution>University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">School of Optometry</institution>, <institution>University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Microbiology and Immunology</institution>, <institution>University of California, San Francisco</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution>Gladstone-UCSF Institute of Genomic Immunology</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-6021"><name><surname>Malissen</surname><given-names>Bernard</given-names></name><role>Reviewing editor</role><aff><institution>Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université</institution>, <country>France</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>j-h-doudna-cate@berkeley.edu</email> (JC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>31</day><month>12</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e74272</elocation-id><history><date date-type="received"><day>28</day><month>09</month><year>2021</year></date><date date-type="accepted"><day>30</day><month>12</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, DeSilva et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>DeSilva et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-74272-v1.pdf"/><abstract><p>Activation of T cells requires a rapid surge in cellular protein synthesis. However, the role of translation initiation in the early induction of specific genes remains unclear. Here we show human translation initiation factor eIF3 interacts with select immune system related mRNAs including those encoding the T cell receptor (TCR) subunits TCRA and TCRB. Binding of eIF3 to the <italic>TCRA</italic> and <italic>TCRB</italic> mRNA 3'-untranslated regions (3'-UTRs) depends on CD28 coreceptor signaling and regulates a burst in TCR translation required for robust T cell activation. Use of the <italic>TCRA</italic> or <italic>TCRB</italic> 3'-UTRs to control expression of an anti-CD19 chimeric antigen receptor (CAR) improves the ability of CAR-T cells to kill tumor cells <italic>in vitro</italic>. These results identify a new mechanism of eIF3-mediated translation control that can aid T cell engineering for immunotherapy applications.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01-GM065050</award-id><principal-award-recipient><name><surname>DeSilva</surname><given-names>Dasmanthie</given-names></name><name><surname>Chin</surname><given-names>Grant H</given-names></name><name><surname>Cate</surname><given-names>Jamie HD</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000884</institution-id><institution>Cancer Research Institute</institution></institution-wrap></funding-source><award-id>N/A</award-id><principal-award-recipient><name><surname>Marson</surname><given-names>Alexander</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100014989</institution-id><institution>Chan Zuckerberg Initiative</institution></institution-wrap></funding-source><award-id>N/A</award-id><principal-award-recipient><name><surname>Apathy</surname><given-names>Ryan A</given-names></name><name><surname>Roth</surname><given-names>Theodore L</given-names></name><name><surname>Marson</surname><given-names>Alexander</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100014220</institution-id><institution>Innovative Genomics Institute</institution></institution-wrap></funding-source><award-id>N/A</award-id><principal-award-recipient><name><surname>Apathy</surname><given-names>Ryan A</given-names></name><name><surname>Roth</surname><given-names>Theodore L</given-names></name><name><surname>Marson</surname><given-names>Alexander</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100014547</institution-id><institution>Parker Institute for Cancer Immunotherapy</institution></institution-wrap></funding-source><award-id>N/A</award-id><principal-award-recipient><name><surname>Marson</surname><given-names>Alexander</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>Tang Prize for Biopharmaceutical Science</institution></institution-wrap></funding-source><award-id>N/A</award-id><principal-award-recipient><name><surname>Cate</surname><given-names>Jamie HD</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001021</institution-id><institution>Damon Runyon Cancer Research Foundation</institution></institution-wrap></funding-source><award-id>DRR#37-15</award-id><principal-award-recipient><name><surname>Ingolia</surname><given-names>Nicholas T</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>DP2 CA195768</award-id><principal-award-recipient><name><surname>Ferguson</surname><given-names>Lucas</given-names></name><name><surname>Kudla</surname><given-names>Marek</given-names></name><name><surname>Ingolia</surname><given-names>Nicholas T</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P30EY003176</award-id><principal-award-recipient><name><surname>Smith</surname><given-names>Benjamin E</given-names></name></principal-award-recipient></award-group><award-group id="par-10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>S10 OD018174</award-id><principal-award-recipient><name><surname>DeSilva</surname><given-names>Dasmanthie</given-names></name></principal-award-recipient></award-group><award-group id="par-11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009417</institution-id><institution>Care-for-Rare Foundation</institution></institution-wrap></funding-source><award-id>N/A</award-id><principal-award-recipient><name><surname>Blaeschke</surname><given-names>Franziska</given-names></name></principal-award-recipient></award-group><award-group id="par-12"><funding-source><institution-wrap><institution>German Research Foundation</institution></institution-wrap></funding-source><award-id>N/A</award-id><principal-award-recipient><name><surname>Blaeschke</surname><given-names>Franziska</given-names></name></principal-award-recipient></award-group><award-group id="par-13"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000861</institution-id><institution>Burroughs Wellcome Fund</institution></institution-wrap></funding-source><award-id>N/A</award-id><principal-award-recipient><name><surname>Marson</surname><given-names>Alexander</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Dasmanthie DeSilva, A provisional patent application has been filed on some of the work presented herein..</p></fn><fn fn-type="conflict" id="conf3"><p>Theodore L Roth, is a co-founder of Arsenal Therapeutics..</p></fn><fn fn-type="conflict" id="conf4"><p>Alexander Marson, is a compensated co-founder, member of the boards of directors, and a member of the scientific advisory boards of Spotlight Therapeutics and Arsenal Biosciences. Was a compensated member of the scientific advisory board at PACT Pharma and was a compensated advisor to Juno Therapeutics. Owns stock in Arsenal Biosciences, Spotlight Therapeutics, PACT Pharma and Merck. A.M. has received fees from Vertex, Merck, Amgen, Trizell, Genentech, AlphaSights, Rupert Case Management and Bernstein. Is an investor in and informal advisor to Offline Ventures. The Marson lab has received research support from Juno Therapeutics, Epinomics, Sanofi, GlaxoSmithKline, Gilead, and Anthem..</p></fn><fn fn-type="conflict" id="conf5"><p>Jamie HD Cate, A provisional patent application has been filed on some of the work presented herein..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Sequencing data has been deposited in GEO (GSE191306).Code used to analyze the microscopy images is available on github at https://github.com/Llamero/TCR_colocalization_analysis-macro</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>De Silva D</collab><collab>Cate JH</collab><collab>Chin G</collab></person-group><year iso-8601-date="2021">2021</year><source>Genome-wide mapping of eIF3-RNA interactions in Jurkat cells using PAR-CLIP</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE191306">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE191306</ext-link><comment>NCBI Gene Expression Omnibus, GSE191306</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-74272-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>